United States · Funded startup

Who invested in Corridor Pharmaceuticals

4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$28Mraised across 4 rounds since 2008, from 4 sources

$2.3MSeed$11MSeries A$13MSeries A$1.6MDebt
Latest round
Debt, $1.6MJan 2013
Biggest round
$13MSeries A · Jun 2010
Investors
9
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20092010201120122013
$2.3MSeed$11MSeries A$13MSeries A$1.6MDebt
First round
Seed, $2.3M
Oct 2008
Biggest round
$13M
Series A · Jun 2010
Usual gap between rounds
11 months
the median of 3

The rounds

  1. Jan 2013
    Debt$1.6M

    No investor was named in the report.

    Reported by sec.govSEC filing: $1.6M sold, first sale Jan 2013

  2. Jun 2010
  3. Oct 2009
  4. Oct 2008

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Quaker PartnersVC firm3rounds
MedImmune VenturesCorporate VC3rounds
AcidophilVC firm2rounds
Domain AssociatesVC firm1round
NewSpringPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Corridor Pharmaceuticals

Who invested in Corridor Pharmaceuticals?

Corridor Pharmaceuticals's investors include Quaker Partners, MedImmune Ventures, Red Abbey Venture Partners, Acidophil and Domain Associates, and 4 more on record.

How much has Corridor Pharmaceuticals raised?

Corridor Pharmaceuticals has raised $28M across 4 rounds since 2008.

When did Corridor Pharmaceuticals last raise?

Corridor Pharmaceuticals's most recent round was a Debt of $1.6M in Jan 2013.

What was Corridor Pharmaceuticals's biggest round?

Corridor Pharmaceuticals's largest round on record is $13M (Series A), in Jun 2010.

Who backed Corridor Pharmaceuticals first?

Corridor Pharmaceuticals's first round on record, in Oct 2008, was backed by Quaker Partners, MedImmune Ventures and Red Abbey Venture Partners and 1 others.

What stage is Corridor Pharmaceuticals at?

Corridor Pharmaceuticals's latest named round is a Debt, in Jan 2013.

Where is Corridor Pharmaceuticals based?

Corridor Pharmaceuticals is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.